David Gonzalez Angulo
CEO, President & DirectorDr. David Gonzalez Angulo, M. D., had been the Chief Medical Officer at SCYNEXIS, Inc. since June 1, 2015. He is President, Director and Chief Executive Officer of SCYNEXIS, Inc. from January 1, 2023. Dr. Angulo served as Vice President of Research & Development at Brickell Biotech, Inc. from October 2010 to May 2015. He served as Senior Director of Global Clinical Research of Stiefel Laboratories, Inc. since 2007. He is an experienced physician specializing in pharmaceutical development. He has led several successful programs in dermatology and other therapy areas in the pharmaceutical industry. Prior to joining Brickell Biotech, he served as the Head of The Clinical and Medical Departments at Stiefel from April 2006 to October 2010. He joined Stiefel in 2006 and served as its Senior Member of the research and development executive team, where he maintained key responsibility for the clinical development programs in dermatology including prescription products, medical devices and cosmetics. Prior to Stiefel, he was responsible for several development programs in the anti-infective area at Schering-Plough Corporation from 1998 to 2006. And before that, he was an Infectious Disease Physician in a Pediatric Hospital. Dr. Angulo has an M. D. from the Universidad de Guadalajara, Mexico and has Post-Graduate Degrees in Pediatrics and Infectious Diseases.
Positions
- Company NameSCYNEXIS, Inc.Stock CodeSCYXPositionCEO, President & DirectorColleagues
- GMGuy MacDonaldIndependent Chairman of the Board
- SSScott SukenickChief Legal Officer & Corporate Secretary
- SSSanjay S. SubramanianChief Financial Officer
- DGDaniella GiganteVice President of Human Resources & Information Technology
- TMTodd MingaSenior Vice President of Research & Development
- AFAnn F. HanhamIndependent Director
- DCDavid C. HastingsIndependent Director
- AAArmando AnidoIndependent Director
